• We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
Logo of annrheumdAnnals of the Rheumatic DiseasesCurrent TOCInstructions for authors
Ann Rheum Dis. Oct 2004; 63(10): 1232–1234.
PMCID: PMC1754764

Better efficacy of methotrexate given by intramuscular injection than orally in patients with rheumatoid arthritis

Abstract

Objective: To compare the clinical efficacy of methotrexate and tolerance to the drug in patients with rheumatoid arthritis who were switched from intramuscular to oral administration because of a shortage of the intramuscular preparation.

Methods: 143 patients were switched from intramuscular to oral methotrexate. Of these, 47 were switched back to the intramuscular form. A multiple choice questionnaire was sent by mail to evaluate clinical and biological criteria of efficacy and tolerance.

Results: When methotrexate was first switched from intramuscular to oral administration, increased disease activity, exacerbation of morning pain and hand stiffness, duration of morning stiffness, increased joint pain, and increased joint swelling were observed. There was a greater frequency of gastrointestinal symptoms, but without a significant increase in liver abnormalities. When intramuscular methotrexate became available again, 47 of the 143 patients were switched back and were followed for at least three months. On average, disease manifestations were improved and side effects reduced by the switch.

Conclusions: Methotrexate given intramuscularly had improved clinical efficacy with fewer side effects than given orally. Intramuscular methotrexate administration should be considered when rheumatoid arthritis remains active in spite of high dose oral methotrexate.

Full Text

The Full Text of this article is available as a PDF (47K).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Letendre PW, DeJong DJ, Miller DR. The use of methotrexate in rheumatoid arthritis. Drug Intell Clin Pharm. 1985 May;19(5):349–358. [PubMed]
  • Haraoui B, Pelletier JP, Cloutier JM, Faure MP, Martel-Pelletier J. Synovial membrane histology and immunopathology in rheumatoid arthritis and osteoarthritis. In vivo effects of antirheumatic drugs. Arthritis Rheum. 1991 Feb;34(2):153–163. [PubMed]
  • Arthur Valerie, Jubb Ronald, Homer Dawn. A study of parenteral use of methotrexate in rheumatic conditions. J Clin Nurs. 2002 Mar;11(2):256–263. [PubMed]
  • Freeman-Narrod M, Gerstley BJ, Engstrom PF, Bornstein RS. Comparison of serum concentrations of methotrexate after various routes of administration. Cancer. 1975 Nov;36(5):1619–1624. [PubMed]
  • Kremer JM, Lee JK. The safety and efficacy of the use of methotrexate in long-term therapy for rheumatoid arthritis. Arthritis Rheum. 1986 Jul;29(7):822–831. [PubMed]
  • Bingham SJ, Buch MH, Lindsay S, Pollard A, White J, Emery P. Parenteral methotrexate should be given before biological therapy. Rheumatology (Oxford) 2003 Aug;42(8):1009–1010. [PubMed]
  • Hamilton RA, Kremer JM. Why intramuscular methotrexate may be more efficacious than oral dosing in patients with rheumatoid arthritis. Br J Rheumatol. 1997 Jan;36(1):86–90. [PubMed]
  • Campbell MA, Perrier DG, Dorr RT, Alberts DS, Finley PR. Methotrexate: bioavailability and pharmacokinetics. Cancer Treat Rep. 1985 Jul-Aug;69(7-8):833–838. [PubMed]
  • Furst DE. Practical clinical pharmacology and drug interactions of low-dose methotrexate therapy in rheumatoid arthritis. Br J Rheumatol. 1995 Nov;34 (Suppl 2):20–25. [PubMed]
  • Rozin A, Schapira D, Balbir-Gurman A, Braun-Moscovici Y, Markovits D, Militianu D, Nahir MA. Relapse of rheumatoid arthritis after substitution of oral for parenteral administration of methotrexate. Ann Rheum Dis. 2002 Aug;61(8):756–757. [PMC free article] [PubMed]
  • Osman A, Mulherin D. Is parenteral methotrexate worth trying? Ann Rheum Dis. 2001 Apr;60(4):432–432. [PMC free article] [PubMed]
  • Burbage G, Gupta R, Lim K. Intramuscular methotrexate in inflammatory rheumatic disease. Ann Rheum Dis. 2001 Dec;60(12):1156–1156. [PMC free article] [PubMed]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Group

Formats:

Related citations in PubMed

See reviews...See all...

Cited by other articles in PMC

See all...

Links

  • Compound
    Compound
    PubChem Compound links
  • MedGen
    MedGen
    Related information in MedGen
  • PubMed
    PubMed
    PubMed citations for these articles
  • Substance
    Substance
    PubChem Substance links

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...